Evidence map›Paper›PMID 31268348›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2019

Histone deacetylase 6 regulates endothelial MyD88-dependent canonical TLR signaling, lung inflammation, and alveolar remodeling in the developing lung.

Heather Menden, Sheng Xia, Sherry M Mabry, Janelle Noel-MacDonnell, Johnson Rajasingh, Shui Qing Ye, Venkatesh Sampath

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Heather MendenDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri.
Sheng XiaDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri.
Sherry M MabryDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri.
Janelle Noel-MacDonnellDivision of Health Services and Outcomes Research, Children's Mercy Hospital, Kansas City, Missouri.
Johnson RajasinghDepartment of Cardiovascular Medicine, Kansas University Medical Center, Kansas City, Missouri.
Shui Qing YeDepartment of Biomedical and Health Informatics, University of Missouri at Kansas City, Kansas City, Missouri.
Venkatesh SampathDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri.
Children's Mercy Hospital · USUniversity Medical Center · USUniversity of Missouri–Kansas City · US

Funding

Inflammatory Angiogenesis in the LungR01HL128374 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI SAMPATH, VENKATESH · 2015 to 2020
$1.8M
NHLBI NIH HHS R01 HL128374
6 · The paper itself

Abstract

Lung endothelial cell (EC) immune activation during bacterial sepsis contributes to acute lung injury and bronchopulmonary dysplasia in premature infants. The epigenetic regulators of sepsis-induced endothelial immune activation, lung inflammation, and alveolar remodeling remain unclear. Herein, we examined the role of the cytoplasmic histone deacetylase, HDAC6, in regulating EC Toll-like receptor 4 (TLR4) signaling and modulating sepsis-induced lung injury in a neonatal model of sterile sepsis. In human primary microvascular endothelial cells (HPMEC), lipopolysaccharide (LPS)-induced MAPK, IKK-β, and p65 phosphorylation as well as inflammatory cytokine expression were exaggerated with the HDAC6 inhibitor tubastatin A, and by dominant-negative HDAC6 with a mutated catalytic domain 2. Expression of HDAC6 wild-type protein suppressed LPS-induced myeloid differentiation primary response 88 (MyD88) acetylation, p65 (Lys

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCytokinesEndothelial CellsHistone Deacetylase 6HumansLipopolysaccharidesLungMiceMyeloid Differentiation Factor 88PneumoniaSignal TransductionToll-Like Receptor 4Adaptor Proteins, Signal TransducingCytokinesHDAC6 protein, humanHistone Deacetylase 6LipopolysaccharidesMyeloid Differentiation Factor 88TLR4 protein, humanToll-Like Receptor 4alveolar remodelingendotheliumHDAC6lung inflammationMyD88 acetylation

Identifiers

PMID31268348
PMCPMC6766719
OpenAlexW2954008282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.